Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LISDEXAMFETAMINE DIMESYLATE vs LOMUSTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LISDEXAMFETAMINE DIMESYLATE vs LOMUSTINE: Safety Overview

Metric LISDEXAMFETAMINE DIMESYLATE LOMUSTINE
Total FAERS Reports 17,054 1,614
Deaths Reported 122 431
Death Rate 0.7% 26.7%
Hospitalizations 2,028 418
Average Patient Age 27.0 yrs 45.5 yrs
% Female Patients 54.7% 42.5%
FDA Approval Date Aug 25, 2023 Approved Prior to Jan 1, 1982
Manufacturer Rhodes Pharmaceuticals Carnegie Pharmaceuticals LLC
Route ORAL ORAL
Marketing Status Prescription Prescription